Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
AIDS: full-pipeline trial registry
4 of 15 indexed AIDS trials are currently recruiting.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 4 currently recruiting · #1,140 of 28,707 conditions by registered trial count
AIDS: 15 US clinical trials tracked, 4 recruiting.
AIDS is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is GlaxoSmithKline, running 2 of these trials.
Enrollment posture brief
Registry condition aids
OPEN 4 | RECR 27% | LATE 2 | EARLY 3 | RANK #1140 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Age-related Macular Degeneration (27% recruiting · 75 trials)
AIDS lists 4 open slots (27% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for AIDS on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
AIDS is recruiting below its size-band peers.
4 of 15 indexed trials (26.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of AIDS trials is spread across many organizations.
GlaxoSmithKline accounts for 2 of 15 trials (13.3%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical AIDS enrolment sits around 100 participants.
Median target enrolment is 100 among the 14 trials that report a genuine target (sentinel values excluded). 6 of those (42.9%) plan for fewer than 100 participants.
-
AIDS research is mostly interventional.
11 interventional and 4 observational studies make up this index (73.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
The DC Cohort Longitudinal HIV Status Neutral Study
George Washington University
NCT01206920
The Collaborative Care PrTNER Study
Children's Hospital of Philadelphia
NCT06585631
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
University of Central Florida
NCT06202898
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
Centers for Disease Control and Prevention
NCT06045923
CSP #512 - Options in Management With Anti-Retrovirals
US Department of Veterans Affairs
NCT00050089
Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
GlaxoSmithKline
NCT01218113
Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
GlaxoSmithKline
NCT01092611
Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")
Stanford University
NCT01985399
Buprenorphine and Integrated HIV Care
Yale University
NCT00317460
Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy
Texas Woman's University
NCT01419314
Exercise and Pioglitazone for HIV-Metabolic Syndromes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00639457
Vitamin D Dose Finding Study
Children's Hospital of Philadelphia
NCT01092338
Switching Undetectables to Selzentry
St. Hope Foundation
NCT01866267
Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression
University of Maryland, Baltimore
NCT00344981
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
National Cancer Institute (NCI)
NCT00491335
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on AIDS records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on AIDS trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this AIDS page
15 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 AIDS trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- GlaxoSmithKline sponsors the most AIDS trials on record, review their full trial history before evaluating a specific study. See GlaxoSmithKline's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This AIDS condition card totals 15 registered trials; most-linked intervention GSK Biologicals HIV Vaccine 732462; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.